Metabolic liver inflammation in obesity does not robustly decrease hepatic and circulating CETP
| Autor: | Yanan Wang, Patrick C.N. Rensen, Aswin Verhoeven, Sander S. Rensen, Zhuang Li, Rico J. E. Derks, Martin Giera, Lisanne L. Blauw, Jan Greve |
|---|---|
| Přispěvatelé: | Surgery, RS: NUTRIM - R2 - Liver and digestive health |
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Male
0301 basic medicine Lipopolysaccharide Biopsy Bariatric Surgery 030204 cardiovascular system & hematology DISEASE Hepatitis chemistry.chemical_compound 0302 clinical medicine Non-alcoholic Fatty Liver Disease TRANSGENIC MICE medicine.diagnostic_test NONALCOHOLIC STEATOHEPATITIS Fatty liver Kupffer cell NASH Middle Aged EXPERIMENTAL ENDOTOXEMIA Receptors Complement medicine.anatomical_structure Liver Liver biopsy Female lipids (amino acids peptides and proteins) medicine.symptom Cardiology and Cardiovascular Medicine MESSENGER-RNA Adult Genetically modified mouse EXPRESSION IN-VITRO medicine.medical_specialty KUPFFER CELLS Inflammation Liver inflammation 03 medical and health sciences ESTER TRANSFER PROTEIN Internal medicine CETP medicine Humans Obesity Messenger RNA business.industry Lipid metabolism medicine.disease Cholesterol Ester Transfer Proteins carbohydrates (lipids) Cross-Sectional Studies 030104 developmental biology Endocrinology chemistry CHOLESTEROL HOMEOSTASIS business Biomarkers |
| Zdroj: | Atherosclerosis, 275, 149-155. Elsevier Ireland Ltd Atherosclerosis Atherosclerosis, 275, 149-155 |
| ISSN: | 0021-9150 |
| Popis: | Background and aims: We recently showed that plasma cholesteryl ester transfer protein (CETP) is mainly derived from VSIG4-positive Kupffer cells. Activation of these cells by the bacterial endotoxin lipopolysaccharide (LPS) strongly decreases CETP expression. As Kupffer cell activation plays a detrimental role in the progression of non-alcoholic fatty liver disease (NAFLD), we aimed to study if metabolic liver inflammation is also associated with a decrease in hepatic and circulating CETP. Methods: We collected plasma and liver biopsy samples at various stages of NAFLD from 93 obese individuals who underwent bariatric surgery. Liver lobular inflammation was histologically determined, and liver CETP expression, CETP positive cells, circulating CETP concentrations, and liver VSIG4 expression were quantified. Results: Mean (SD) plasma CETP concentration was 2.68 (0.89) mu g/mL. In the presence of liver inflammation, compared to the absence of pathology, the difference in hepatic CETP expression was -0.03 arbitrary units (95% CI -0.26, 0.20), the difference in number of hepatic CETP positive cells (range 11-140 per mm(2)) was -20.0 per mm(2) (95% CI -41.6, 1.9), and the difference in plasma CETP was -0.35 mu g/mL (95% CI -0.80, 0.10). Hepatic VSIG4 expression was not associated with liver inflammation (0.00; 95% CI -0.15, 0.15). Conclusions: We found no strong evidence for a strong negative association between metabolic liver inflammation and CETP-related outcomes in obese individuals, although we observed consistent trends. These data indicate that metabolic liver inflammation does not mimic the strong effects of LPS on the hepatic expression and production of CETP by Kupffer cells. (C) 2018 The Authors. Published by Elsevier B.V. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect